Closing

Closing is asking for, and getting, the buyer's commitment. Popular culture treats it as a dark art of pressure lines; real B2B closing is the opposite: if discovery, value demonstration and objection handling were done well, closing is the natural last step — the buyer expects the ask and is relieved when it comes.

If closing feels like a wrestling move, the problem is upstream. Hard-closing an unconvinced NHS buyer doesn't work even once: cycles are long, buying is collective, and pressure poisons the relationship.

That said, you must ask. Deals die of politeness — sellers waiting to be offered the business. The ask is direct and unembarrassed: "Sounds like we've resolved everything on the list — are you ready to move forward?"

Trial closes

Trial closes are low-stakes temperature checks en route — testing commitment without asking for the order: "If the pilot hits these criteria, what happens next?" "Who else needs to be comfortable before this goes ahead?" The answers tell you whether you're closing ground or drifting, months before the final ask.

Next-step discipline

Every call ends with a specific, calendared next step, booked before you hang up. Not "I'll follow up soon" — "Thursday 2pm with you and the IG lead; invite coming now."

A deal without a scheduled next step isn't a deal; it's a hope. In pipeline reviews, "what's the next step and is it in the diary?" is a good manager's first question.

The mutual action plan

A mutual action plan (close plan) is a shared document — often just a table — listing every step from today to go-live with owners and dates on both sides: technical validation, IG review and DPIA, business case, procurement steps, contract, signature, deployment.

It surfaces hidden steps early, turns closing from something you do to the buyer into a project you run with them, and slippage against it is your early warning of a deal in trouble. For long, multi-stakeholder NHS deals, working without one is malpractice.

End-of-quarter dynamics, seller side

Quotas are typically quarterly, so quarter-end concentrates pressure — and tempts you to discount for speed (section 5 is how buyers exploit exactly that). The professional stance:

• build the timeline from the buyer's process via the mutual action plan, not your fiscal calendar;
• make any date-based incentive a genuine trade;
• never let a rushed deal become the reference customer who felt pressured.

Field note

Buyers can smell quarter-end. Experienced procurement teams keep note of vendors' fiscal calendars, and the rep who found 15% in the last week of March has taught that customer what every future renewal will look like. The discounts that leak out at quarter-end rarely close deals that weren't closing anyway — they just reprice them.

Ghosting and the break-up email

Ghosting — the prospect stops replying — usually means shifted priorities, a blocking stakeholder, or avoidance of saying no.

After two or three varied, value-adding follow-ups (a relevant case study, a useful article — never "just checking in", which offers nothing), send the break-up email: short, warm, pressure-free — "I don't want to clutter your inbox, so I'll assume the timing isn't right and close the file for now. If I've misread it, one line back and we'll pick it straight up."

It's costless to answer and gives a genuine no permission to be said — a striking share of dead threads revive in response. Either way you get an answer, and pipeline built on answers beats pipeline built on hope.

Field note

The break-up email works partly because so few sellers can bring themselves to send it. Writing a genuinely useful follow-up is work, so most reps default to "just checking in" — which is exactly why a warm, pressure-free closing of the file stands out in an inbox and gets answered. Send it only when you mean it: the versions that revive dead threads are the ones that have genuinely let go.

7. Losing well

You will lose deals — to competitors, to budgets, and above all to inertia. Losing well is a professional skill.

Run a loss review on every significant loss: what actually happened, decided by whom, on what criteria — not the story that flatters you. Ask the buyer directly where you can; post-decision, people are candid, and "we'd already chosen before your first meeting" is priceless correction. Log it honestly in the CRM (customer relationship management system — Salesforce and similar) so patterns become visible.

Keep doors open. Congratulate them on a sound process, wish the chosen supplier well, ask permission to stay in touch. UK health tech is a small, networked market: the person who rejected you moves trusts, the winning vendor stumbles at implementation, and the gracious runner-up gets the first call. Some of the best deals are lost deals that came back eighteen months later.

"No decision" is your biggest competitor. Across B2B, more forecasted deals die to the buyer doing nothing — the status quo — than to any named rival; studies put no-decision at 40–60% of qualified pipeline. The implications run backwards through everything:

• sell the cost of inaction as hard as your differentiators;
• qualify for genuine urgency, not polite interest;
• fight stalling deals with champions, business cases and mutual action plans, not feature lists.

Asked in an interview who a company's biggest competitor is, "honestly, the status quo — most B2B deals die by inaction, and here's how you fight that" is the answer of someone who understands how deals are really lost.

Voice from the field

As Matthew Dixon and Ted McKenna show in The JOLT Effect (2022), between 40% and 60% of qualified deals are lost not to a competitor but to no decision — and in most of those losses the buyer actually wanted to change and froze anyway, afraid of choosing wrongly. Their counter-intuitive finding: piling more fear of missing out onto an indecisive buyer makes things worse, not better. What works is de-risking the decision itself — a clear recommendation, fewer options, safety nets against a bad outcome.

Cost-of-inaction beats status-quo preference; for the indecisive buyer, de-risking (pilots, guarantees, phased rollout) beats more FOMO — diagnose which loss you're facing first.